Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 96 | 2023 | 3079 | 6.900 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 18 | 2017 | 518 | 2.770 |
Why?
|
Fatigue | 8 | 2021 | 1530 | 2.350 |
Why?
|
Brain | 100 | 2023 | 26345 | 2.230 |
Why?
|
Magnetic Resonance Imaging | 153 | 2023 | 35409 | 2.220 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 11 | 2023 | 236 | 1.890 |
Why?
|
Atrophy | 31 | 2020 | 1577 | 1.710 |
Why?
|
Nerve Fibers, Myelinated | 11 | 2011 | 957 | 1.340 |
Why?
|
Disease Progression | 31 | 2022 | 13273 | 0.880 |
Why?
|
Subtraction Technique | 4 | 2011 | 523 | 0.860 |
Why?
|
Leukoencephalopathies | 5 | 2019 | 238 | 0.850 |
Why?
|
Medial Forebrain Bundle | 1 | 2021 | 45 | 0.770 |
Why?
|
Anti-Anxiety Agents | 1 | 2023 | 390 | 0.730 |
Why?
|
Imaging, Three-Dimensional | 13 | 2018 | 4033 | 0.720 |
Why?
|
Image Interpretation, Computer-Assisted | 15 | 2019 | 3320 | 0.710 |
Why?
|
Cognition Disorders | 14 | 2015 | 4041 | 0.710 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 6 | 2019 | 236 | 0.690 |
Why?
|
Image Processing, Computer-Assisted | 30 | 2018 | 8939 | 0.660 |
Why?
|
Neurofilament Proteins | 4 | 2022 | 318 | 0.560 |
Why?
|
Gait | 7 | 2011 | 795 | 0.540 |
Why?
|
Image Enhancement | 13 | 2020 | 2915 | 0.530 |
Why?
|
Aging | 15 | 2021 | 8655 | 0.520 |
Why?
|
Cerebrovascular Disorders | 4 | 2013 | 1504 | 0.510 |
Why?
|
Longitudinal Studies | 29 | 2020 | 13980 | 0.470 |
Why?
|
Mobility Limitation | 4 | 2013 | 409 | 0.460 |
Why?
|
Spinal Cord | 6 | 2020 | 1809 | 0.450 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2021 | 2739 | 0.440 |
Why?
|
Reproducibility of Results | 29 | 2023 | 19894 | 0.430 |
Why?
|
Thalamus | 5 | 2021 | 1023 | 0.430 |
Why?
|
Corpus Callosum | 6 | 2018 | 736 | 0.430 |
Why?
|
Male | 137 | 2023 | 349776 | 0.420 |
Why?
|
Gait Disorders, Neurologic | 2 | 2011 | 233 | 0.400 |
Why?
|
Physicians' Offices | 1 | 2011 | 58 | 0.400 |
Why?
|
Diffusion Tensor Imaging | 10 | 2018 | 2305 | 0.400 |
Why?
|
Meningeal Neoplasms | 1 | 2020 | 1241 | 0.400 |
Why?
|
Adult | 98 | 2023 | 213889 | 0.390 |
Why?
|
Humans | 187 | 2023 | 743811 | 0.390 |
Why?
|
Neuropsychological Tests | 18 | 2016 | 6976 | 0.390 |
Why?
|
Nerve Regeneration | 2 | 2007 | 788 | 0.380 |
Why?
|
Movement Disorders | 3 | 2005 | 448 | 0.380 |
Why?
|
Female | 127 | 2023 | 380020 | 0.370 |
Why?
|
Blood Pressure | 7 | 2019 | 8551 | 0.370 |
Why?
|
Algorithms | 20 | 2021 | 13869 | 0.360 |
Why?
|
Middle Aged | 82 | 2023 | 213241 | 0.360 |
Why?
|
Interferon-beta | 4 | 2014 | 324 | 0.350 |
Why?
|
Pattern Recognition, Automated | 4 | 2015 | 1001 | 0.350 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2009 | 141 | 0.340 |
Why?
|
Delirium | 5 | 2019 | 1611 | 0.330 |
Why?
|
Anisotropy | 5 | 2021 | 1263 | 0.320 |
Why?
|
Internet | 1 | 2020 | 3058 | 0.320 |
Why?
|
Anatomy, Artistic | 1 | 2008 | 52 | 0.310 |
Why?
|
Mathematical Computing | 2 | 2006 | 147 | 0.310 |
Why?
|
Corpus Striatum | 1 | 2014 | 1219 | 0.310 |
Why?
|
Disability Evaluation | 13 | 2013 | 1828 | 0.310 |
Why?
|
Medical Illustration | 1 | 2008 | 132 | 0.300 |
Why?
|
Glial Fibrillary Acidic Protein | 3 | 2023 | 528 | 0.300 |
Why?
|
Gadolinium | 7 | 2020 | 950 | 0.290 |
Why?
|
Walking | 3 | 2011 | 1182 | 0.290 |
Why?
|
Medulla Oblongata | 1 | 2008 | 243 | 0.290 |
Why?
|
Sensitivity and Specificity | 18 | 2017 | 14714 | 0.290 |
Why?
|
Cardiac Output | 1 | 2009 | 854 | 0.280 |
Why?
|
HLA Antigens | 2 | 2010 | 1382 | 0.270 |
Why?
|
Depression | 4 | 2021 | 7760 | 0.270 |
Why?
|
Gadolinium DTPA | 4 | 2007 | 836 | 0.270 |
Why?
|
Artifacts | 8 | 2008 | 1904 | 0.260 |
Why?
|
Macaca mulatta | 2 | 2008 | 2375 | 0.250 |
Why?
|
Seasons | 1 | 2010 | 1493 | 0.240 |
Why?
|
Information Management | 1 | 2005 | 101 | 0.240 |
Why?
|
Hypoxia, Brain | 1 | 2004 | 133 | 0.230 |
Why?
|
Statistics as Topic | 3 | 2009 | 2369 | 0.230 |
Why?
|
Friedreich Ataxia | 2 | 2013 | 76 | 0.220 |
Why?
|
Anxiety | 1 | 2017 | 4288 | 0.210 |
Why?
|
Severity of Illness Index | 18 | 2020 | 15526 | 0.210 |
Why?
|
Prospective Studies | 23 | 2023 | 53250 | 0.200 |
Why?
|
Cerebellum | 4 | 2018 | 1487 | 0.200 |
Why?
|
Nerve Degeneration | 1 | 2006 | 748 | 0.200 |
Why?
|
Cross-Sectional Studies | 13 | 2023 | 25032 | 0.190 |
Why?
|
Aged, 80 and over | 26 | 2019 | 57744 | 0.190 |
Why?
|
Cerebrovascular Circulation | 5 | 2016 | 2732 | 0.190 |
Why?
|
Models, Neurological | 3 | 2010 | 1771 | 0.190 |
Why?
|
Cerebral Veins | 2 | 2016 | 156 | 0.180 |
Why?
|
Aged | 39 | 2019 | 163178 | 0.180 |
Why?
|
Central Nervous System | 2 | 2006 | 1358 | 0.180 |
Why?
|
Brain Ischemia | 3 | 2016 | 3264 | 0.180 |
Why?
|
Spinal Cord Injuries | 1 | 2008 | 931 | 0.180 |
Why?
|
Brain Mapping | 14 | 2016 | 6622 | 0.180 |
Why?
|
Cognition | 10 | 2020 | 6759 | 0.180 |
Why?
|
Contrast Media | 7 | 2020 | 5301 | 0.180 |
Why?
|
Follow-Up Studies | 21 | 2019 | 39001 | 0.170 |
Why?
|
Immunologic Factors | 5 | 2013 | 1580 | 0.170 |
Why?
|
Memory, Short-Term | 3 | 2023 | 976 | 0.160 |
Why?
|
Aquaporin 4 | 1 | 2019 | 153 | 0.160 |
Why?
|
Retinal Hemorrhage | 1 | 2018 | 96 | 0.150 |
Why?
|
Retinal Artery | 1 | 2018 | 111 | 0.150 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2010 | 1813 | 0.150 |
Why?
|
Magnetic Resonance Angiography | 1 | 2004 | 1444 | 0.150 |
Why?
|
Speech | 1 | 2022 | 541 | 0.150 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2023 | 477 | 0.150 |
Why?
|
Elasticity Imaging Techniques | 1 | 2022 | 388 | 0.150 |
Why?
|
Antihypertensive Agents | 2 | 2019 | 2047 | 0.140 |
Why?
|
Wine | 1 | 2017 | 165 | 0.140 |
Why?
|
Hypertension | 4 | 2019 | 8480 | 0.140 |
Why?
|
Optic Nerve | 1 | 2020 | 554 | 0.140 |
Why?
|
Alzheimer Disease | 7 | 2022 | 8035 | 0.140 |
Why?
|
Echo-Planar Imaging | 5 | 2007 | 659 | 0.140 |
Why?
|
Retrospective Studies | 16 | 2023 | 77410 | 0.140 |
Why?
|
Heart Diseases | 1 | 2009 | 2789 | 0.130 |
Why?
|
Postoperative Complications | 5 | 2019 | 15281 | 0.130 |
Why?
|
Artificial Intelligence | 4 | 2023 | 2210 | 0.130 |
Why?
|
Memory Disorders | 2 | 2016 | 1186 | 0.130 |
Why?
|
Neuromyelitis Optica | 1 | 2019 | 252 | 0.130 |
Why?
|
Confidentiality | 1 | 2019 | 613 | 0.130 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2002 | 1524 | 0.130 |
Why?
|
Urinary Incontinence | 2 | 2010 | 496 | 0.130 |
Why?
|
Middle Cerebral Artery | 2 | 2013 | 264 | 0.130 |
Why?
|
Parietal Lobe | 3 | 2008 | 832 | 0.120 |
Why?
|
Models, Theoretical | 2 | 2006 | 3587 | 0.120 |
Why?
|
Nerve Fibers | 1 | 1998 | 687 | 0.120 |
Why?
|
Models, Biological | 2 | 2021 | 9582 | 0.120 |
Why?
|
Stereotaxic Techniques | 1 | 1996 | 535 | 0.120 |
Why?
|
Cephalometry | 1 | 2016 | 379 | 0.120 |
Why?
|
Pyramidal Tracts | 1 | 2016 | 255 | 0.120 |
Why?
|
Demyelinating Diseases | 1 | 2016 | 354 | 0.120 |
Why?
|
Predictive Value of Tests | 12 | 2016 | 15067 | 0.120 |
Why?
|
Dementia | 1 | 2008 | 2518 | 0.110 |
Why?
|
Models, Statistical | 5 | 2015 | 5100 | 0.110 |
Why?
|
Regression Analysis | 8 | 2015 | 6457 | 0.110 |
Why?
|
Organ Size | 5 | 2017 | 2241 | 0.110 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2013 | 264 | 0.110 |
Why?
|
Analysis of Variance | 4 | 2018 | 6356 | 0.110 |
Why?
|
Mental Processes | 1 | 2013 | 247 | 0.110 |
Why?
|
Theory of Mind | 1 | 2013 | 85 | 0.100 |
Why?
|
HLA-B Antigens | 2 | 2010 | 354 | 0.100 |
Why?
|
Young Adult | 17 | 2017 | 56392 | 0.100 |
Why?
|
Prognosis | 7 | 2016 | 29052 | 0.100 |
Why?
|
Stroke | 3 | 2023 | 9975 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 6 | 2004 | 3758 | 0.100 |
Why?
|
Thalamic Nuclei | 1 | 2012 | 112 | 0.100 |
Why?
|
Microvessels | 1 | 2016 | 544 | 0.100 |
Why?
|
Consensus | 2 | 2020 | 2954 | 0.100 |
Why?
|
Psychomotor Performance | 2 | 2013 | 1895 | 0.100 |
Why?
|
Drug Substitution | 1 | 2014 | 281 | 0.100 |
Why?
|
Brain Diseases | 2 | 2018 | 1558 | 0.100 |
Why?
|
Skull | 1 | 2016 | 812 | 0.100 |
Why?
|
Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 38 | 0.100 |
Why?
|
Cohort Studies | 10 | 2019 | 40545 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 5 | 2013 | 17439 | 0.100 |
Why?
|
Software | 4 | 2018 | 4440 | 0.100 |
Why?
|
Executive Function | 3 | 2019 | 1361 | 0.100 |
Why?
|
Papillomavirus Infections | 1 | 2023 | 1587 | 0.100 |
Why?
|
Pulmonary Embolism | 1 | 2023 | 2375 | 0.090 |
Why?
|
Temporal Lobe | 2 | 2008 | 1656 | 0.090 |
Why?
|
Head | 1 | 1996 | 878 | 0.090 |
Why?
|
Caudate Nucleus | 1 | 2012 | 392 | 0.090 |
Why?
|
AIDS Dementia Complex | 1 | 2011 | 154 | 0.090 |
Why?
|
Normal Distribution | 2 | 2009 | 280 | 0.090 |
Why?
|
Reaction Time | 1 | 2016 | 2091 | 0.090 |
Why?
|
Facial Expression | 1 | 2013 | 508 | 0.090 |
Why?
|
Motor Activity | 2 | 2016 | 2714 | 0.090 |
Why?
|
Albuterol | 1 | 2010 | 208 | 0.090 |
Why?
|
Cerebral Cortex | 5 | 2013 | 5692 | 0.090 |
Why?
|
User-Computer Interface | 2 | 2007 | 1431 | 0.090 |
Why?
|
Hippocampus | 3 | 2016 | 3672 | 0.080 |
Why?
|
HLA-DR Antigens | 1 | 2010 | 645 | 0.080 |
Why?
|
Erythropoietin | 1 | 2013 | 726 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2023 | 2736 | 0.080 |
Why?
|
Double-Blind Method | 7 | 2013 | 12020 | 0.080 |
Why?
|
Demography | 2 | 2013 | 1653 | 0.080 |
Why?
|
Disabled Persons | 2 | 2013 | 1214 | 0.080 |
Why?
|
Risk Factors | 12 | 2019 | 72252 | 0.080 |
Why?
|
Fuzzy Logic | 1 | 2007 | 56 | 0.080 |
Why?
|
Peptides | 2 | 2010 | 4406 | 0.080 |
Why?
|
Poisson Distribution | 1 | 2009 | 513 | 0.070 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2009 | 323 | 0.070 |
Why?
|
Immunosuppressive Agents | 2 | 2012 | 4152 | 0.070 |
Why?
|
Blood-Brain Barrier | 4 | 2015 | 1018 | 0.070 |
Why?
|
Reference Values | 5 | 2009 | 4974 | 0.070 |
Why?
|
Gene Frequency | 2 | 2010 | 3585 | 0.070 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2009 | 1108 | 0.070 |
Why?
|
Preoperative Care | 1 | 2016 | 2251 | 0.070 |
Why?
|
Radionuclide Imaging | 1 | 2011 | 2034 | 0.070 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2006 | 2540 | 0.070 |
Why?
|
Feasibility Studies | 3 | 2013 | 5078 | 0.070 |
Why?
|
Recurrence | 4 | 2021 | 8337 | 0.070 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2009 | 629 | 0.070 |
Why?
|
Verbal Learning | 2 | 2009 | 468 | 0.070 |
Why?
|
Receptor, Bradykinin B1 | 1 | 2005 | 10 | 0.070 |
Why?
|
Computational Biology | 1 | 2018 | 3515 | 0.070 |
Why?
|
Recovery of Function | 1 | 2016 | 2922 | 0.070 |
Why?
|
Time | 1 | 2007 | 542 | 0.070 |
Why?
|
Observer Variation | 3 | 2018 | 2592 | 0.070 |
Why?
|
Vaccines, Subunit | 1 | 2005 | 168 | 0.060 |
Why?
|
Time Factors | 11 | 2020 | 40038 | 0.060 |
Why?
|
Echocardiography, Doppler | 1 | 2009 | 935 | 0.060 |
Why?
|
Societies, Medical | 1 | 2016 | 3740 | 0.060 |
Why?
|
Perfusion | 1 | 2009 | 1359 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 3965 | 0.060 |
Why?
|
Reference Standards | 1 | 2008 | 1023 | 0.060 |
Why?
|
Electromagnetic Fields | 1 | 2006 | 298 | 0.060 |
Why?
|
Quality of Life | 2 | 2017 | 12788 | 0.060 |
Why?
|
Statistics, Nonparametric | 4 | 2011 | 2883 | 0.060 |
Why?
|
Adolescent | 14 | 2016 | 85729 | 0.060 |
Why?
|
Calibration | 1 | 2006 | 816 | 0.060 |
Why?
|
Apolipoprotein E4 | 1 | 2008 | 668 | 0.060 |
Why?
|
HIV | 1 | 2011 | 1604 | 0.060 |
Why?
|
Dominance, Cerebral | 1 | 2005 | 626 | 0.060 |
Why?
|
Dyspnea | 1 | 2011 | 1303 | 0.060 |
Why?
|
beta-Lactams | 1 | 2005 | 159 | 0.060 |
Why?
|
Genetic Loci | 1 | 2013 | 2575 | 0.060 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2005 | 232 | 0.060 |
Why?
|
Age Distribution | 1 | 2009 | 2899 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2013 | 2583 | 0.050 |
Why?
|
Alleles | 2 | 2010 | 6934 | 0.050 |
Why?
|
Sirolimus | 1 | 2010 | 1565 | 0.050 |
Why?
|
Intermediate Filaments | 1 | 2023 | 175 | 0.050 |
Why?
|
Pilot Projects | 4 | 2022 | 8316 | 0.050 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2011 | 1872 | 0.050 |
Why?
|
Medication Adherence | 1 | 2014 | 2063 | 0.050 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2005 | 340 | 0.050 |
Why?
|
Information Dissemination | 2 | 2021 | 1099 | 0.050 |
Why?
|
Logistic Models | 6 | 2017 | 13404 | 0.050 |
Why?
|
Age of Onset | 1 | 2009 | 3268 | 0.050 |
Why?
|
Cerebral Arteries | 1 | 2004 | 494 | 0.050 |
Why?
|
Linear Models | 4 | 2018 | 5952 | 0.050 |
Why?
|
Activities of Daily Living | 1 | 2011 | 2419 | 0.050 |
Why?
|
Placebos | 2 | 2021 | 1674 | 0.050 |
Why?
|
Smoking | 2 | 2009 | 8984 | 0.050 |
Why?
|
Patient Satisfaction | 1 | 2014 | 3391 | 0.050 |
Why?
|
Geriatric Assessment | 1 | 2009 | 1372 | 0.050 |
Why?
|
Auditory Cortex | 1 | 2005 | 345 | 0.050 |
Why?
|
Immunoconjugates | 1 | 2008 | 901 | 0.050 |
Why?
|
Prevalence | 3 | 2019 | 15211 | 0.050 |
Why?
|
Treatment Outcome | 9 | 2019 | 63042 | 0.050 |
Why?
|
Monocytes | 2 | 2013 | 2593 | 0.050 |
Why?
|
Ultrasonography, Doppler, Transcranial | 2 | 2013 | 292 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2010 | 2715 | 0.050 |
Why?
|
Diffusion | 3 | 2015 | 831 | 0.050 |
Why?
|
Iron | 1 | 2009 | 1774 | 0.050 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2008 | 859 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2914 | 0.050 |
Why?
|
Adjuvants, Immunologic | 2 | 2010 | 999 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2012 | 4561 | 0.040 |
Why?
|
Hydroxyquinolines | 1 | 1999 | 19 | 0.040 |
Why?
|
Hand | 1 | 2005 | 884 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7270 | 0.040 |
Why?
|
Computer Simulation | 3 | 2009 | 6188 | 0.040 |
Why?
|
Databases as Topic | 1 | 2021 | 474 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2006 | 2712 | 0.040 |
Why?
|
Neurons | 2 | 2022 | 9336 | 0.040 |
Why?
|
Incidence | 4 | 2023 | 20948 | 0.040 |
Why?
|
Plaque, Amyloid | 1 | 2022 | 729 | 0.040 |
Why?
|
Hemoglobin SC Disease | 1 | 1996 | 22 | 0.040 |
Why?
|
Biological Assay | 1 | 2020 | 650 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 1999 | 595 | 0.040 |
Why?
|
Erythrocytes | 2 | 1996 | 2455 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 3047 | 0.040 |
Why?
|
Bone Marrow | 2 | 1999 | 2951 | 0.040 |
Why?
|
T-Lymphocyte Subsets | 2 | 2006 | 1837 | 0.040 |
Why?
|
Chi-Square Distribution | 3 | 2010 | 3503 | 0.040 |
Why?
|
Laser Therapy | 2 | 1993 | 1071 | 0.030 |
Why?
|
Acoustic Stimulation | 3 | 2005 | 1209 | 0.030 |
Why?
|
Phenotype | 3 | 2013 | 16361 | 0.030 |
Why?
|
Motor Cortex | 2 | 2003 | 986 | 0.030 |
Why?
|
Automation, Laboratory | 1 | 2016 | 101 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2005 | 1783 | 0.030 |
Why?
|
Amygdala | 1 | 2003 | 1313 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1999 | 1159 | 0.030 |
Why?
|
Hydroxyurea | 1 | 1996 | 289 | 0.030 |
Why?
|
Anti-HIV Agents | 1 | 2011 | 4255 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6487 | 0.030 |
Why?
|
Pentetic Acid | 1 | 1995 | 213 | 0.030 |
Why?
|
Postural Balance | 1 | 2000 | 621 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2023 | 1911 | 0.030 |
Why?
|
Meglumine | 1 | 1995 | 149 | 0.030 |
Why?
|
Electrodes | 1 | 1997 | 616 | 0.030 |
Why?
|
Age Factors | 4 | 2013 | 18355 | 0.030 |
Why?
|
HIV Infections | 2 | 2011 | 16715 | 0.030 |
Why?
|
Intracellular Membranes | 1 | 1995 | 391 | 0.030 |
Why?
|
Phorbol Esters | 1 | 2013 | 111 | 0.030 |
Why?
|
Glioblastoma | 2 | 2019 | 3480 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5532 | 0.030 |
Why?
|
Tumor Burden | 1 | 2019 | 1917 | 0.030 |
Why?
|
Animals | 7 | 2022 | 168660 | 0.030 |
Why?
|
Face | 1 | 2019 | 993 | 0.030 |
Why?
|
Genotype | 3 | 2013 | 12944 | 0.030 |
Why?
|
Epidemiologic Methods | 1 | 2018 | 1364 | 0.030 |
Why?
|
Morbidity | 1 | 2018 | 1768 | 0.030 |
Why?
|
Body Fluid Compartments | 1 | 1992 | 52 | 0.030 |
Why?
|
Chemokine CXCL10 | 1 | 2013 | 305 | 0.030 |
Why?
|
Oxygen | 4 | 2005 | 4189 | 0.030 |
Why?
|
Gene Expression | 1 | 2005 | 7793 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 2006 | 10179 | 0.030 |
Why?
|
Accidental Falls | 1 | 2019 | 1062 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 1995 | 665 | 0.020 |
Why?
|
Comorbidity | 2 | 2019 | 10380 | 0.020 |
Why?
|
Receptors, Interleukin-2 | 2 | 2005 | 573 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2023 | 3476 | 0.020 |
Why?
|
Interferon-gamma | 2 | 2010 | 3205 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2013 | 6539 | 0.020 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2012 | 310 | 0.020 |
Why?
|
Brain Edema | 1 | 1995 | 617 | 0.020 |
Why?
|
Glutamine | 1 | 2013 | 579 | 0.020 |
Why?
|
Knee Joint | 2 | 1999 | 1680 | 0.020 |
Why?
|
HLA-C Antigens | 1 | 2010 | 147 | 0.020 |
Why?
|
Axons | 1 | 2018 | 1685 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2014 | 1586 | 0.020 |
Why?
|
Drug Combinations | 1 | 1995 | 1958 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2013 | 21733 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2010 | 232 | 0.020 |
Why?
|
Child | 4 | 2013 | 77637 | 0.020 |
Why?
|
Arginine | 1 | 2013 | 943 | 0.020 |
Why?
|
Sex Factors | 2 | 2007 | 10394 | 0.020 |
Why?
|
Cerebrospinal Fluid | 1 | 1992 | 533 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2022 | 9731 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2000 | 5524 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 29777 | 0.020 |
Why?
|
Adrenergic beta-Agonists | 1 | 2010 | 346 | 0.020 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2011 | 367 | 0.020 |
Why?
|
Interleukin-13 | 1 | 2010 | 389 | 0.020 |
Why?
|
Lipids | 1 | 1999 | 3307 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2023 | 11036 | 0.020 |
Why?
|
Urination | 1 | 2009 | 204 | 0.020 |
Why?
|
Somatosensory Cortex | 2 | 2003 | 525 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2011 | 1525 | 0.020 |
Why?
|
Physical Therapy Modalities | 1 | 2011 | 549 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2011 | 1423 | 0.020 |
Why?
|
Occipital Lobe | 1 | 2009 | 377 | 0.020 |
Why?
|
Entorhinal Cortex | 1 | 2008 | 271 | 0.020 |
Why?
|
Brain Infarction | 1 | 2009 | 299 | 0.020 |
Why?
|
Social Behavior | 1 | 2013 | 1126 | 0.020 |
Why?
|
Third Ventricle | 1 | 2007 | 76 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2010 | 10940 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2005 | 7172 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2013 | 941 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8660 | 0.020 |
Why?
|
Forced Expiratory Volume | 1 | 2011 | 1740 | 0.020 |
Why?
|
Attention | 1 | 2016 | 2393 | 0.020 |
Why?
|
Complementarity Determining Regions | 1 | 2006 | 149 | 0.020 |
Why?
|
Immunologic Tests | 1 | 2006 | 103 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2011 | 4386 | 0.020 |
Why?
|
Piperacillin | 1 | 2005 | 40 | 0.020 |
Why?
|
Central Nervous System Neoplasms | 1 | 1993 | 895 | 0.020 |
Why?
|
Ceftazidime | 1 | 2005 | 68 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18027 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2011 | 2560 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 1994 | 1848 | 0.020 |
Why?
|
Differential Threshold | 1 | 2004 | 80 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2012 | 1904 | 0.020 |
Why?
|
Brain Neoplasms | 2 | 1998 | 8856 | 0.020 |
Why?
|
Area Under Curve | 1 | 2009 | 1654 | 0.020 |
Why?
|
Thoracic Vertebrae | 1 | 2009 | 608 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 9944 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2013 | 4204 | 0.020 |
Why?
|
Models, Structural | 1 | 2004 | 361 | 0.010 |
Why?
|
Genes, MHC Class II | 1 | 2005 | 457 | 0.010 |
Why?
|
Amoxicillin | 1 | 2005 | 169 | 0.010 |
Why?
|
Cephalosporins | 1 | 2005 | 203 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2022 | 21824 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2007 | 929 | 0.010 |
Why?
|
Markov Chains | 1 | 2007 | 968 | 0.010 |
Why?
|
Body Water | 2 | 1995 | 343 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2703 | 0.010 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2006 | 675 | 0.010 |
Why?
|
Odds Ratio | 2 | 2010 | 9848 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2617 | 0.010 |
Why?
|
Mathematics | 1 | 2004 | 727 | 0.010 |
Why?
|
Immune System | 1 | 2008 | 807 | 0.010 |
Why?
|
Gyrus Cinguli | 1 | 2009 | 1091 | 0.010 |
Why?
|
Cervical Vertebrae | 1 | 2009 | 976 | 0.010 |
Why?
|
RNA, Viral | 1 | 2011 | 2901 | 0.010 |
Why?
|
Rotation | 1 | 2004 | 522 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2013 | 15518 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2011 | 1854 | 0.010 |
Why?
|
Clinical Competence | 1 | 2018 | 4687 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4931 | 0.010 |
Why?
|
Individuality | 1 | 2004 | 307 | 0.010 |
Why?
|
Viral Load | 1 | 2011 | 3300 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2013 | 4422 | 0.010 |
Why?
|
Information Storage and Retrieval | 1 | 2007 | 824 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2008 | 15142 | 0.010 |
Why?
|
Electroencephalography | 1 | 1997 | 6061 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2007 | 2971 | 0.010 |
Why?
|
Dichotic Listening Tests | 1 | 2001 | 22 | 0.010 |
Why?
|
Educational Status | 1 | 2009 | 2540 | 0.010 |
Why?
|
Phantoms, Imaging | 2 | 1999 | 2479 | 0.010 |
Why?
|
Cause of Death | 1 | 2011 | 3580 | 0.010 |
Why?
|
Hemodynamics | 1 | 2011 | 4197 | 0.010 |
Why?
|
Acute Disease | 1 | 2011 | 7150 | 0.010 |
Why?
|
Fingers | 1 | 2003 | 513 | 0.010 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2000 | 91 | 0.010 |
Why?
|
Models, Genetic | 1 | 2010 | 3492 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1998 | 9239 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3608 | 0.010 |
Why?
|
Cues | 1 | 2005 | 874 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20121 | 0.010 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2001 | 250 | 0.010 |
Why?
|
Smoking Cessation | 1 | 2011 | 2071 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 8637 | 0.010 |
Why?
|
Radiography | 1 | 2010 | 7010 | 0.010 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2004 | 717 | 0.010 |
Why?
|
Memory | 1 | 2009 | 2173 | 0.010 |
Why?
|
Software Design | 1 | 1999 | 176 | 0.010 |
Why?
|
United States | 2 | 2018 | 69859 | 0.010 |
Why?
|
Boston | 1 | 2011 | 9310 | 0.010 |
Why?
|
Spin Labels | 1 | 1999 | 332 | 0.010 |
Why?
|
Radiotherapy, High-Energy | 1 | 1998 | 228 | 0.010 |
Why?
|
Glioma | 1 | 1993 | 3401 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4749 | 0.010 |
Why?
|
Erythrocyte Aggregation | 1 | 1996 | 36 | 0.010 |
Why?
|
Movement | 1 | 2003 | 1471 | 0.010 |
Why?
|
Anion Exchange Protein 1, Erythrocyte | 1 | 1996 | 153 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2011 | 12954 | 0.010 |
Why?
|
Triethyltin Compounds | 1 | 1995 | 4 | 0.010 |
Why?
|
Intracellular Fluid | 1 | 1996 | 203 | 0.010 |
Why?
|
Arousal | 1 | 2001 | 1160 | 0.010 |
Why?
|
Ion Transport | 1 | 1996 | 320 | 0.010 |
Why?
|
Language | 1 | 2005 | 1468 | 0.010 |
Why?
|
Hydrogen | 1 | 1996 | 164 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 12066 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2001 | 1869 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12243 | 0.010 |
Why?
|
Mice | 1 | 2022 | 81154 | 0.010 |
Why?
|
Intraoperative Care | 1 | 1998 | 767 | 0.010 |
Why?
|
Child, Preschool | 2 | 2013 | 40964 | 0.010 |
Why?
|
Hematocrit | 1 | 1996 | 636 | 0.010 |
Why?
|
Fetal Hemoglobin | 1 | 1996 | 341 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 12354 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2001 | 1395 | 0.010 |
Why?
|
Chlorides | 1 | 1996 | 667 | 0.010 |
Why?
|
Water | 1 | 2000 | 1394 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 1999 | 1676 | 0.010 |
Why?
|
Extracellular Space | 1 | 1996 | 595 | 0.010 |
Why?
|
Functional Laterality | 1 | 2001 | 2280 | 0.010 |
Why?
|
PUVA Therapy | 1 | 1993 | 98 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2005 | 3778 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2005 | 5096 | 0.010 |
Why?
|
Lung | 1 | 2011 | 9858 | 0.010 |
Why?
|
Potassium | 1 | 1996 | 1336 | 0.010 |
Why?
|
Research Design | 1 | 2008 | 5983 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 3874 | 0.010 |
Why?
|
Hospitalization | 1 | 2011 | 10259 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 1993 | 862 | 0.010 |
Why?
|
Triglycerides | 1 | 1999 | 2453 | 0.010 |
Why?
|
Laser Coagulation | 1 | 1993 | 326 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12259 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23398 | 0.010 |
Why?
|
Cell Adhesion | 1 | 1996 | 3144 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2005 | 13028 | 0.010 |
Why?
|
Forecasting | 1 | 1999 | 2950 | 0.010 |
Why?
|
Neural Pathways | 1 | 2001 | 2971 | 0.010 |
Why?
|
Hemoglobins | 1 | 1996 | 1531 | 0.010 |
Why?
|
Hypothalamus | 1 | 1995 | 1061 | 0.010 |
Why?
|
Radiosurgery | 1 | 1998 | 1331 | 0.010 |
Why?
|
Rabbits | 1 | 1995 | 4894 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1997 | 6030 | 0.000 |
Why?
|
Bone Marrow Cells | 1 | 1994 | 2509 | 0.000 |
Why?
|
Fatty Acids | 1 | 1994 | 1809 | 0.000 |
Why?
|
Lipid Metabolism | 1 | 1994 | 1885 | 0.000 |
Why?
|
Endothelium, Vascular | 1 | 1996 | 4459 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1999 | 7908 | 0.000 |
Why?
|
Rats | 1 | 1993 | 24250 | 0.000 |
Why?
|